Apollo Hospital Ent.
Ticker > Company >

Apollo Hospital Ent. share price

Apollo Hospitals Enterprise Ltd.

NSE: APOLLOHOSP BSE: 508869 SECTOR: Hospital & Healthcare Services  2.37 L   858   126

7882.00
+2.50 (0.03%)
NSE: Today, 12:34 PM

Price Summary

Today's High

₹ 7915

Today's Low

₹ 7841.5

52 Week High

₹ 7980

52 Week Low

₹ 6001

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 113331.07 Cr.

Enterprise Value

₹ 114520.17 Cr.

No. of Shares

14.38 Cr.

P/E

83.86

P/B

12.54

Face Value

₹ 5

Div. Yield

0.24 %

Book Value (TTM)

₹  628.79

CASH

₹ 594.1 Cr.

DEBT

₹ 1783.2 Cr.

Promoter Holding

29.34 %

EPS (TTM)

₹  93.99

Sales Growth

12.76%

ROE

15.77 %

ROCE

19.25%

Profit Growth

28.28 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Apollo Hospitals Enterprise Ltd.

Da Vinci BPOSITIVE HealthHiway LIFE STUDIO LIFE CENTER ATNF LIFE STUDIO MEDVARSITY

Index Presence

The company is present in 50Indices.

NIFTY100WEIGHT

Nifty100 Equal Weight
33182.2
  86.3999999999942 (0.261060315810457%)

NIFTYSERVICE

Nifty Services Sector
32601.7
  146.650000000001 (0.451855720450278%)

NIFTYEQWGT

NIFTY50 Equal Weight
32149.75
  106.549999999999 (0.332519848204926%)

NFTALLO30

NIFTY Alpha Low-Volatility 30
26801.25
  87.5499999999993 (0.327734458349083%)

NIFTY100

Nifty 100
25747.9
  109.150000000001 (0.425722782896987%)

NIFTYLOWVOL

Nifty Low Volatility 50
25318.25
  27.5999999999985 (0.109131240201421%)

NIFTY

Nifty 50
25118.25
  112.75 (0.450900801823595%)

NIFTY500

Nifty 500
23191.85
  89.1999999999971 (0.386102892958151%)

NIFTY500LOWVOL50

Nifty500 Low Volatility 50 Index
22509.6
  72.5 (0.323125537614044%)

NT100LOW30

Nifty100 Low Volatility 30
20640.85
  15.7999999999993 (0.0766058748948417%)

NT100ALP30

NIFTY100 Alpha 30
18546.15
  81.6000000000022 (0.44192791050961%)

NIF500LGMIDSML

Nifty500 LargeMidSmall Equal-Cap Weighted Index
17832.75
  60.2000000000007 (0.338724606204521%)

NIFTYLGEMID250

NIFTY LargeMidcap 250
16288.75
  56.5 (0.348072509972441%)

NY500MUL50:25:25

Nifty500 Multicap 50:25:25
16164.45
  58.1000000000004 (0.360727290789042%)

NIFTYHEALTH

Nifty Healthcare Index
14741.8
  57.5499999999993 (0.391916509184997%)

NFT500EQUAL

Nifty 500 Equal Weight
14415.3
  33.5999999999985 (0.233630238427995%)

NIFTY200

Nifty 200
14012.95
  55.9500000000007 (0.400874113348149%)

NY500MULI50:30:20

Nifty500 Multicap Infrastructure 50:30:20
13968.1
  53.3999999999996 (0.383766807764441%)

NIFTYTOTALMCAP

Nifty Total Market index
13052.9
  48.6499999999996 (0.374108464540446%)

NIFTYCONSUMP

Nifty India Consumption
12403.65
  -7.75 (-0.0624425930998873%)

NI15

NI15
12078.8
  7.09999999999854 (0.0588152455743396%)

NIFTYINFRAST

Nifty Infrastructure
9088
  45.2999999999993 (0.500956572705036%)

SHARIAH25

Nifty Shariah 25
8388.2
  -5.89999999999964 (-0.0702874638138673%)

SHARIAH500

Nifty500 Shariah
7195.3
  12.75 (0.177513557162845%)

NIFTYFULLMIDCAP100

NIFTY FULL MIDCAP 100
5987.56
  -42.7999999999993 (-0.709742038617911%)

NIFTY100ESG

NIFTY100 ESG
4995.9
  13.6499999999996 (0.273972602739714%)

SHARIAHNIF

Nifty50 Shariah
4723.3
  11.8500000000004 (0.251514926402718%)

NIFTY100ESGSECT

Nifty100 ESG Sector Leaders
4231.7
  16.25 (0.385486721465078%)

BSE HC

S&P Bse Healthcare
44934.23
  132.640000000007 (0.296060921052144%)

BSEINDEX

BSE Index
38993.1
  130.589999999997 (0.336030791629249%)

BSE500

S&P Bse 500
36418.47
  130.559999999998 (0.359789252122811%)

SS6535

BSE Sensex Sixty 65:35
34230.82
  140.589999999997 (0.412405548451855%)

SNSX60

BSE Sensex Sixty
33752.43
  144.519999999997 (0.430017814258599%)

BSE100

S&P Bse 100
26315.01
  105.429999999997 (0.402257495160163%)

SNSX50

S&P Bse Sensex50
26207.55
  121.459999999999 (0.465612132749671%)

BSEIND150

BSE India 150 Index
18750.18
  71.0400000000009 (0.380317295121735%)

200EQW

BSE 200 Equal Weight
13037.05
  23.0099999999984 (0.176809046230053%)

BSE200

S&P Bse 200
11390.62
  41.5600000000013 (0.366197729151141%)

BSE1000

Bse 1000
10851.51
  37.2800000000007 (0.344730970212392%)

LMI250

S&P Bse 250 LargeMidCap
10824.44
  39.4200000000001 (0.365506971707052%)

S&P LARGEMIDCAP

S&P Bse Large MidCap
10319.66
  72.75 (0.709970127579918%)

ALLCAP

S&P Bse Allcap
10130.99
  38.3799999999992 (0.380278243189802%)

LRGCAP

S&P Bse LargeCap
9675.7
  39.130000000001 (0.406057341979582%)

BSE100LARGECAPTMC

S&P Bse 100 LargeCap TMC
9273.83
  37.75 (0.408723181263038%)

SHA500

S&P Bse 500 Shariah
9113.66
  125.5 (1.39628133010539%)

GREENEX

S&P Bse Greenex
7827.5
  33.6300000000001 (0.431492955361068%)

CARBONEX

S&P Bse Carbonex
4344.48
  15.7799999999997 (0.364543627417002%)

SPBSLVIP

S&P Bse Low Volatility
1848.91
  1.88000000000011 (0.101785027855539%)

S&PDIVSTABLE

S&P Bse Dividend Stability
1000.33
  0.460000000000036 (0.0460059807775082%)

ESG100

S&P Bse 100 ESG Index
420.31
  1.70999999999998 (0.408504538939325%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year12.76%
3 Year10.38%
5 Year-3.49%

Profit Growth

1 Year28.28%
3 Year24.91%
5 Year22.49%

ROE%

1 Year15.77%
3 Year15.41%
5 Year11.15%

ROCE %

1 Year19.25%
3 Year17.96%
5 Year14.4%

Debt/Equity

0.2042

Price to Cash Flow

65.06

Interest Cover Ratio

7.6476

CFO/PAT (5 Yr. Avg.)

1.59331589506565

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 29.34 0.00
Mar 2025 29.34 13.47
Dec 2024 29.33 13.47
Sep 2024 29.33 13.99
Jun 2024 29.33 16.09
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 31.3136913742251% for the Past 3 years.
  • The Company has been maintaining an effective average operating margins of 22.7824571481983% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -86.6904 days.
  • Company has a healthy liquidity position with current ratio of 2.4421.
  • The company has a good cash flow management; CFO/PAT stands at 1.59331589506565.

 Limitations

  • The company has shown a poor revenue growth of 10.383712338981% for the Past 3 years.
  • The company is trading at a high PE of 83.86.
  • The company is trading at a high EV/EBITDA of 46.3694.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 1936.6 2135.4 2054.8 2075.3 2167.9
Total Expenditure 1465.8 1595.1 1543 1554 1621.8
Operating Profit 470.8 540.3 511.8 521.3 546.1
Other Income 27.3 120.9 107.9 91.6 32.5
Interest 63.5 65.4 62 63.1 58.8
Depreciation 102.9 108.3 108.4 129.8 123.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 331.7 487.5 449.3 420 396.6
Tax 80 117.9 107.7 86.6 89.7
Profit After Tax 251.7 369.6 341.6 333.4 306.9
Adjusted EPS (Rs) 17.51 25.7 23.76 23.19 21.34

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 4653.9 6098.3 6524.8 7273.8 8202.1
Total Expenditure 3945 4678.9 4843.3 5476.3 6158
Operating Profit 708.9 1419.4 1681.5 1797.5 2044.1
Other Income 21.1 47 151.5 179.9 347.7
Interest 340 244 238.8 249.8 254
Depreciation 421.3 363.4 366.7 399 449.3
Exceptional Items -9.1 -6.7 0 0 0
Profit Before Tax -40.4 852.3 1227.5 1328.6 1688.5
Tax -14 279.8 142.7 318.1 392.2
Net Profit 105 665.2 1084.8 1010.5 1296.3
Adjusted EPS (Rs.) -1.84 39.81 75.44 70.27 90.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 71.9 71.9 71.9 71.9 71.9
Total Reserves 5129.6 6038.8 6852.9 7639 8662.3
Borrowings 1965.4 1908.1 1520.1 1785.5 1553.5
Other N/C liabilities 2065.1 2402.6 2594 1587 1703
Current liabilities 1521.3 1189.2 1243.3 1370.2 1440.7
Total Liabilities 10753.3 11610.6 12282.2 12453.6 13431.4
Assets
Net Block 5038 5120.8 5078 6031.6 6348.1
Capital WIP 196.9 22.4 89 172.5 294
Intangible WIP 22.3 1.5 7.4 27.2 12.5
Investments 1134.5 1558.3 1925.6 1937.7 2479
Loans & Advances 1314.9 1440.6 1987.6 556 709.6
Other N/C Assets 9 11.8 43.9 53.5 69.8
Current Assets 3037.7 3455.2 3150.7 3675.1 3518.4
Total Assets 10753.3 11610.6 12282.2 12453.6 13431.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 176.6 994.8 1227.5 1328.6 1701.8
Adjustment 887.2 654.2 493 506.2 395.4
Changes in Assets & Liabilities -152.3 -349.6 -172.6 -313.4 19.7
Tax Paid 3.8 -98.5 -323.4 -330 -375
Operating Cash Flow 915.3 1200.9 1224.5 1191.4 1741.9
Investing Cash Flow -781 -504 -588.5 -835.3 -1045.7
Financing Cash Flow -175.7 -576.6 -778.6 -297 -739.1
Net Cash Flow -41.4 120.3 -142.6 59.1 -42.9

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 29.33 29.33 29.33 29.34 29.34
dr. prathap c reddy 0.17 0.17 0.17 0.17 0.17
m/s. indian hospitals cor... 0.04 0.04 0.04 0.04 0.04
m/s. obul reddy investmen... 0.01 0.01 0.01 0.01 0.01
m/s. pcr investments ltd 18.93 18.93 18.93 18.93 18.93
mr. konda anindith reddy... 0.16 0.16 0.16 0.16 0.16
mr. aditya reddy 0.01 0.01 0.01 0.01 0.01
mr. dwaraknath reddy 0.01 0.01 0.01 0.01 0.01
mr. harshad reddy 0.23 0.23 0.23 0.23 0.23
mr. k vishweshwar reddy 1.10 1.10 1.10 1.10 1.10
mr. karthik anand 0.24 0.24 0.24 0.24 0.24
mr. konda viraj madhav re... 0.12 0.12 0.12 0.12 0.12
mr. konda vishwajit reddy... 0.15 0.15 0.15 0.15 0.15
mr. puansh kamineni 0.15 0.15 0.15 0.15 0.15
mr. vijay kumar reddy 0.01 0.01 0.01 0.01 0.01
ms. anuspala kamineni 0.18 0.18 0.18 0.18 0.18
ms. preetha reddy 0.73 0.73 0.73 0.73 0.73
ms. sangita reddy 1.69 1.69 1.69 1.69 1.69
ms. shobana kamineni 1.56 1.56 1.56 1.56 1.56
ms. sindoori reddy 0.22 0.22 0.22 0.22 0.22
ms. sucharitha p reddy 0.12 0.12 0.12 0.12 0.12
ms. suneeta reddy 3.36 3.36 3.36 3.36 3.36
ms. upasana konidela 0.15 0.15 0.15 0.15 0.15
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 70.67 70.67 70.67 70.66 70.66
aditya birla sun life tru... 1.07 - - - 1.14
axis mutual fund trustee ... - - - 1.23 1.27
franklin india flexi cap ... - - - 1.06 1.12
government of singapore 2.26 1.94 1.64 1.76 1.49
government pension fund g... 1.34 1.34 1.13 1.13 1.14
hdfc trustee company limi... 3.41 2.94 2.53 2.38 1.62
invesco india contra fund... - - - - 1.23
investor education and pr... 0.35 - 0.37 0.37 0.36
kotak funds - india midca... 1.10 1.07 1.07 1.07 1.02
life insurance corporatio... 2.86 3.56 3.74 3.77 2.17
llp 0.01 0.01 0.02 0.02 0.02
mirae asset midcap fund - - - - 2.21
nippon life india trustee... 1.12 - - 1.04 1.20
sbi nifty 50 etf 1.46 1.40 1.46 1.41 1.45
schroder international se... 1.53 1.46 1.28 1.17 1.03
mirae asset elss tax save... 1.93 1.33 1.05 1.88 -
axis focused fund account... - - 1.13 - -
nps trust 1.04 1.05 1.10 - -
investor education and pr... - 0.35 - - -
axis mutual fund trustee ... 1.17 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit FITCH
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research Geojit
Research HDFC Securities
Research Edelweiss

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q3FY21
Concall Q2FY24
Concall Q2FY21
Concall Q1FY26
Concall Q1FY25
Concall Q1FY24
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY21
Presentation Q2FY23
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY21
Presentation FY2019

Company News

Apollo Hospitals Enterprise informs about disclosure 29 Aug, 5:30 PM Apollo Hospitals Enterprise gets nod to acquire 50% stake of Apollo Gleneagles PET-CT 13 Aug, 3:41 PM Apollo Hospitals Enterprise reports 42% jump in Q1 consolidated net profit 13 Aug, 3:28 PM Apollo Hospital Ent. - Quaterly Results 12 Aug, 7:15 PM Apollo Hospital Ent. - Quaterly Results 12 Aug, 7:15 PM Apollo Hospitals Enterprise submits BRSR 7 Aug, 5:27 PM Apollo Hospitals Enterprise joins hands with Siemens Healthineers 24 Jul, 2:38 PM Apollo Hospitals Enterprise reports 60% jump in Q4 consolidated net profit 2 Jun, 11:48 AM Apollo Hospital Ent. - Quaterly Results 30 May, 6:04 PM Apollo Hospital Ent. - Quaterly Results 30 May, 6:04 PM Apollo Hospital Ent. - Quaterly Results 30 May, 6:04 PM Apollo Hospitals Enterprise informs about board meeting 6 May, 3:15 PM Apollo Hospitals Enterprise, IBA partner to introduce Proteus One system in India 5 Mar, 9:05 AM Apollo Hospitals Enterprise reports 49% jump in Q3 consolidated net profit 11 Feb, 3:41 PM Apollo Hospital Ent. - Quaterly Results 10 Feb, 7:24 PM Apollo Hospital Ent. - Quaterly Results 10 Feb, 7:24 PM Apollo Hospital Ent. - Quaterly Results 10 Feb, 7:24 PM Apollo Hospitals Enterprise’s JV launches heart valve clinic 4 Feb, 11:39 AM Apollo Hospitals Enterprise signs MoU with Mayapada Healthcare Group 27 Jan, 12:11 PM Apollo Hospitals Enterprise’s arm to acquire business from Searchlight Health 26 Dec, 2:12 PM Apollo Hospitals Enterprise reports 59% rise in Q2 consolidated net profit 6 Nov, 5:17 PM Apollo Hospital Ent. - Quaterly Results 6 Nov, 3:42 PM Apollo Hospital Ent. - Quaterly Results 6 Nov, 3:42 PM Apollo Hospital Ent. - Quaterly Results 6 Nov, 3:42 PM Apollo Hospitals to build 500-bed hospital in Mumbai 4 Nov, 10:13 AM Apollo Hospitals Enterprise informs about details of loss of certificate 18 Oct, 5:55 PM Apollo Hospitals Enterprise informs about loss of share certificate 11 Sep, 3:49 PM Apollo Hospitals Enterprise informs about details of loss of certificate 5 Sep, 5:24 PM Apollo Hospitals Enterprise’s arm incorporates wholly owned subsidiary 4 Sep, 5:43 PM Apollo Hospitals reports strong Q1 numbers; consolidated net profit up 82% 14 Aug, 12:17 PM Apollo Hospital Ent. - Quaterly Results 13 Aug, 7:01 PM Apollo Hospital Ent. - Quaterly Results 13 Aug, 7:01 PM Apollo Hospital Ent. - Quaterly Results 13 Aug, 7:01 PM Apollo Hospitals Enterprise informs about loss of share certificate 19 Jul, 5:21 PM Apollo Hospitals Enterprise informs about loss of share certificate 13 Jun, 1:37 PM Apollo Hospitals Enterprise reports 77% rise in Q4 consolidated net profit 31 May, 10:30 AM Apollo Hospital Ent. - Quaterly Results 30 May, 7:01 PM Apollo Hospital Ent. - Quaterly Results 30 May, 7:01 PM Apollo Hospitals Enterprise informs about loss of share certificate 29 May, 12:06 PM Apollo Hospitals Enterprise informs about change in directorate 2 Apr, 3:26 PM Apollo Hospitals Enterprise informs about loss of share certificate 28 Feb, 5:21 PM Apollo Hospital Ent. - Quaterly Results 8 Feb, 2:35 PM Apollo Hospital Ent. - Quaterly Results 8 Feb, 2:35 PM Apollo Hospital Ent. - Quaterly Results 8 Feb, 2:35 PM Apollo Hospitals Enterprise informs about loss of share certificate 19 Jan, 5:15 PM Apollo Hospitals Enterprise informs about closure of trading window 23 Dec, 11:19 AM Apollo Hospitals Enterprise informs about details of loss of certificate 21 Nov, 4:46 PM Apollo Hospitals Enterprise gets nod for expansion plan 9 Nov, 4:35 PM Apollo Hospital Ent. - Quaterly Results 9 Nov, 2:35 PM Apollo Hospital Ent. - Quaterly Results 9 Nov, 2:35 PM

Apollo Hospital Ent. Stock Price Analysis and Quick Research Report. Is Apollo Hospital Ent. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Apollo Hospital Ent.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Apollo Hospital Ent. has a PE ratio of 83.972819744092 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Apollo Hospital Ent. has ROA of 10.0158% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Apollo Hospital Ent. has a Current ratio of 2.4421.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Apollo Hospital Ent. has a ROE of 15.7652%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Apollo Hospital Ent. has a Debt to Equity ratio of 0.2042 which means that the company has low proportion of debt in its capital.

  • Sales growth: Apollo Hospital Ent. has reported revenue growth of 12.7622% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Apollo Hospital Ent. for the current financial year is 24.9216664025067%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Apollo Hospital Ent. is Rs 19 and the yield is 0.2411%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Apollo Hospital Ent. is Rs 93.9947. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Apollo Hospital Ent. in Ticker for free. Also, one can get the intrinsic value of Apollo Hospital Ent. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Apollo Hospital Ent. FAQs

Q1. What is Apollo Hospital Ent. share price today?
Ans: The current share price of Apollo Hospital Ent. is Rs 7893.

Q2. What is the market capitalisation of Apollo Hospital Ent.?
Ans: Apollo Hospital Ent. has a market capitalisation of Rs 113489.2297701 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Apollo Hospital Ent.?
Ans: The PE ratio of Apollo Hospital Ent. is 83.972819744092 and the P/B ratio of Apollo Hospital Ent. is 12.5526006927547, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Apollo Hospital Ent. share?
Ans: The 52-week high share price of Apollo Hospital Ent. is Rs 7980, and the 52-week low share price of Apollo Hospital Ent. is Rs 6001.

Q5. Does Apollo Hospital Ent. pay dividends?
Ans: Currently, Apollo Hospital Ent. pays dividends. Dividend yield of Apollo Hospital Ent. is around 0.2411%.

Q6. What are the face value and book value of Apollo Hospital Ent. shares?
Ans: The face value of Apollo Hospital Ent. shares is Rs 5, while the book value per share of Apollo Hospital Ent. is around Rs 628.794. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Apollo Hospital Ent.?
Ans: Apollo Hospital Ent. has a total debt of Rs 1783.2 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Apollo Hospital Ent.?
Ans: The ROE of Apollo Hospital Ent. is 15.7652% and ROCE of Apollo Hospital Ent. is 19.2479%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Apollo Hospital Ent. a good buy for the long term?
Ans: The Apollo Hospital Ent. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Apollo Hospital Ent. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Apollo Hospital Ent. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Apollo Hospital Ent.’s financials?
Ans: You can review Apollo Hospital Ent.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Apollo Hospital Ent.

Apollo Hospitals Enterprise Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Apollo Hospitals Enterprise Ltd. is one of the leading healthcare providers in India. In this article, we will provide a comprehensive analysis of Apollo Hospitals Enterprise Ltd.'s stock from a long-term investor's perspective. We will cover various topics such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Apollo Hospitals Enterprise Ltd. Share Price:

Apollo Hospitals Enterprise Ltd.'s share price is a crucial indicator of investor sentiment towards the company. The share price is influenced by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to analyze Apollo Hospitals Enterprise Ltd.'s share price and identify any trends or patterns. The company's share price has shown a steady upward trend over the past few years, reflecting the company's strong financial performance and growth prospects.

Apollo Hospitals Enterprise Ltd. Balance Sheet:

Apollo Hospitals Enterprise Ltd.'s balance sheet provides crucial information about its financial health. The company's assets include fixed assets, investments, and other assets, while liabilities include loans, trade payables, and other liabilities. Equity includes share capital, reserves, and surplus. Long-term investors can use our pre-built screening tools to analyze Apollo Hospitals Enterprise Ltd.'s balance sheet and identify any red flags. The company's balance sheet has remained strong over the past few years, reflecting the company's low debt levels and strong operating cash flows. 

Apollo Hospital Enterprise Reserves

Apollo Hospital Enterprise has also invested in reserves and it records a rise from ?3,918.80 crores in March 2020 to ?7,639 crores in March 2024. This has been an indication of a constantly increasing financial health of the company, and its performance to retain its earned resources over the years.

Borrowings of Apollo Hospital Enterprise Limited  

There is a clear indication of borrowing control by reducing borrowing from ?2,499.70 crores in 2020 to ?1,785.50 crores in 2024. This reduction fits with the management’s interest of improving cash management, and reducing the amount of interest expense incurred.

The current liability is also sometimes referred to as the non-current liability, the non-current liability is a liability that formula55684877 does not have to be settled in the short term and therefore is a non-current liability. 

There was a minor oscillation of current liabilities which have stood at ? 1,370.20 crores in 2024. A rise in non –current liabilities to ?3,362 crores refers to more long-term commitments having been made, perhaps for developing more centers for health care.

Assets of Apollo Hospital Enterprise  

The total number of assets increased from ?11,112 crores in March 2020 to ?14,228.60 crores in March 2024. The scale of fixed assets (Net Block) increased significantly to ?6,031.60 crores in 2024 which clearly indicates that the company has invested in fixed assets. Investments also showed an increase of ? 1,937.70 crore in the year 2024.

Balance Sheet Overview of Apollo Hospital Enterprise’s Expanding Health Care Services  

This analysis has been derived using the balance sheet figures of Apollo Hospital Enterprise Ltd taken independently.

Those shareholders interested in tracking healthcare stocks such as Apollo Hospital Enterprise should make use of superior stock filters to compare the performance of healthcare stocks because the healthcare industry remains to be well represented in both NSE as well as the BSE.

Apollo Hospitals Enterprise Ltd. Annual Report:

Apollo Hospitals Enterprise Ltd. releases an annual report every year, which provides detailed information about the company's financial performance, strategic initiatives, and future plans. The annual report includes a letter from the Chairman, financial statements, and management discussion and analysis. Long-term investors can download Apollo Hospitals Enterprise Ltd.'s annual report from our website and use it to make informed investment decisions. The annual report provides valuable insights into the company's operations and financial performance.

Apollo Hospitals Enterprise Ltd. Dividend:

Apollo Hospitals Enterprise Ltd. has a consistent dividend history. The company has paid dividends every year, reflecting its commitment to rewarding shareholders. Long-term investors should consider this when evaluating Apollo Hospitals Enterprise Ltd.'s stock. Our pre-built screening tools can be used to analyze the company's dividend history and identify any trends or patterns.

Apollo Hospitals Enterprise Ltd. Quarterly Results:

Apollo Hospitals Enterprise Ltd. releases its quarterly results every three months. The quarterly results provide information about the company's revenue, earnings, and expenses. Long-term investors can use our pre-built screening tools to analyze Apollo Hospitals Enterprise Ltd.'s quarterly results and identify any trends or patterns. The quarterly results are an important indicator of the company's financial health and performance.

Apollo Hospitals Enterprise Ltd. Stock Price:

The stock price of Apollo Hospitals Enterprise Ltd. is affected by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to track Apollo Hospitals Enterprise Ltd.'s stock price and identify potential buying opportunities. The stock price of Apollo Hospitals Enterprise Ltd. has shown a steady upward trend over the past few years, reflecting the company's strong financial performance and growth prospects.

Apollo Hospitals Enterprise Ltd. Price Chart:

A price chart provides a visual representation of a company's stock price over a period of time. Long-term investors can use our pre-built screening tools to analyze Apollo Hospitals Enterprise Ltd.'s price chart and identify any trends or patterns. The price chart shows that the stock price of Apollo Hospitals Enterprise Ltd. has shown a steady upward trend over the past few years, reflecting the company's strong financial performance and growth prospects.

Apollo Hospitals Enterprise Ltd. News:

Keeping up to date with the latest news about Apollo Hospitals Enterprise Ltd. is important for investors. Our website provides the latest news about Apollo Hospitals Enterprise Ltd. from various sources such as financial news websites and social media. Long-term investors can use this information to make informed investment decisions.

Apollo Hospitals Enterprise Ltd. Concall:

Apollo Hospitals Enterprise Ltd. holds conference calls with analysts and investors to discuss its financial performance and future plans. Long-term investors can listen to Apollo Hospitals Enterprise Ltd.'s concall and use the information provided to make informed investment decisions. Our website provides information about upcoming concalls and links to listen to past concalls.

Apollo Hospitals Enterprise Ltd. Transcripts:

Transcripts of Apollo Hospitals Enterprise Ltd.'s concalls are available on our website. Long-term investors can download the transcripts and use them to analyze the company's financial performance and future plans. The transcripts provide valuable insights into the company's operations and financial performance.

Apollo Hospitals Enterprise Ltd. Investor Presentations:

Apollo Hospitals Enterprise Ltd. provides investor presentations on its website. These presentations provide information about the company's financial performance, strategic initiatives, and future plans. Long-term investors can download Apollo Hospitals Enterprise Ltd.'s investor presentations from our website and use them to make informed investment decisions. The investor presentations provide valuable insights into the company's operations and financial performance.

Apollo Hospitals Enterprise Ltd. Promoters:

Promoters are individuals or entities that have a significant stake in a company. Apollo Hospitals Enterprise Ltd.'s promoters include the Apollo Group, which holds a significant stake in the company. Long-term investors can use our pre-built screening tools to analyze Apollo Hospitals Enterprise Ltd.'s promoter holdings and identify any potential conflicts of interest. The promoter holdings of Apollo Hospitals Enterprise Ltd. are relatively stable, which is a positive sign for long-term investors.

Apollo Hospitals Enterprise Ltd. Shareholders:

Apollo Hospitals Enterprise Ltd. has a large number of shareholders, including institutional investors and individual investors. Long-term investors can use our pre-built screening tools to analyze Apollo Hospitals Enterprise Ltd.'s shareholder base and identify any potential risks or opportunities. The shareholder base of Apollo Hospitals Enterprise Ltd. is diverse, which is a positive sign for long-term investors.

Apollo Hospitals Enterprise Ltd. Premium Features:

Our website provides premium features tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools can help long-term investors make better investment decisions by providing more detailed insights into the company's financial performance and valuation.

Apollo Hospitals Enterprise Limited ROCE

The Return on Capital Employed (ROCE) is a key financial ratio used to measure the profitability and efficiency of a company. For Apollo Hospitals Enterprise Limited, the ROCE shows the return generated from the capital employed in its operations. By analyzing the ROCE, investors can assess the effectiveness of the company's capital investments and its ability to generate profits.

Apollo Hospitals Enterprise Limited EBITDA

EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization, is a measure of a company's profitability. For Apollo Hospitals Enterprise Limited, the EBITDA provides insight into its operating performance by excluding non-operating expenses. By examining the EBITDA, investors can gauge the company's ability to generate earnings from its core operations.

Apollo Hospitals Enterprise Limited DPS

Dividend Per Share (DPS) is a financial measure that indicates the amount of cash a company distributes to its shareholders per share. For Apollo Hospitals Enterprise Limited, the DPS reflects the company's dividend policy and its commitment to returning value to shareholders. By examining the DPS, investors can assess the company's dividend history and its ability to generate consistent cash flows.

Apollo Hospitals Enterprise Limited EPS

Earnings Per Share (EPS) is a widely used financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. For Apollo Hospitals Enterprise Limited, the EPS provides insight into its profitability and the value it creates for shareholders. By analyzing the EPS, investors can evaluate the company's earnings potential and compare it with industry peers.

Apollo Hospitals Operating Revenue Annual Growth in Q2FY25  

Apollo Hospitals have posted standalone net sales of Rs 2,135.40 crore for quarter ended September 2024 (Q2 FY25), which 14.4% YoY up as compared to the Rs 1,866.50 crore posted in the same quarter last fiscal ended September 2023 (Q2 FY24). Net Sales were up by 10.3% from Rs 1936.60 Cr in the same Period of June 2024 (Q1 FY25). This affirms the company’s capability to spur solid revenue increase resulting from growth of healthcare services as well as the numbers of patients seeking the services.  

Revenue operating profit increase in Q2FY25  

The company’s operating profit was Rs 540.30 crore, up by 12.8% YoY in Q2 FY25 compared to Rs 479.10 crore for the Q2 FY24. In sequence, operating profit increased by 14.7%, from Rs 470.80 crore in Q1 FY25. The margins improved because of better cost controls on sales revenue and the operating profit margin rose to 25.3% from 24.3% of the previous quarter.  

Profit Before Tax and PAT Performance  

The company achieved PBT of Rs 487.50 crore in Q2FY25, with an annual YoY rise of 24.8% than Rs 390.70 crore of the corresponding Q2FY24 and a QoQ growth of a healthy 46.9% over Rs 331.70 crore of Q1FY25. Following tax adjustments of Rs 117.90 crore, profit after tax (PAT) rose further to Rs 369.60 crore, a 25.4% YoY uptick from Rs 294.80 crore of Q2 FY24 and 46.8% up from Rs 251.70 crore of Q1 FY25.  

The EPS on the other hand strengthens in September 2024.  

The EPS on this adjusted basis further swollen to Rs 25.70 in Q2 FY25 from Rs 20.50 in Q2 FY24, an YoY increment of 25.4%. Alphabetically, it was up 46.8% from Rs 17.51 in Q1 FY25, proving improved shareholder value.  

This data is the result of the company analysis by observing the Standalone Quarterly Results of Apollo Hospitals. It may also be observed that healthcare has remained a stable sector with reference to the overall market trends on NSE and BSE indices among investors.

Read More
X